Nice healthy increase in NPAT of $35-$36m & based on Q1 with less cyclical nature than with SACC.
Looks like they're just going to run down SACC business rather than sell it so expect a restructuring charge in H2 impacting that NPAT estimate.
Fortunately plenty of cash on hand to manage that.
All good with no mention of senate enquiry impacting the business.
Ann: AGM Presentation, page-2
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
